ATE479431T1 - Verwendung einer kombination von substanzen der porphyrinsynthese, salicylaten und antioxidantien bei der phototherapie von haut- und/oder gelenkerkrankungen - Google Patents
Verwendung einer kombination von substanzen der porphyrinsynthese, salicylaten und antioxidantien bei der phototherapie von haut- und/oder gelenkerkrankungenInfo
- Publication number
- ATE479431T1 ATE479431T1 AT03815354T AT03815354T ATE479431T1 AT E479431 T1 ATE479431 T1 AT E479431T1 AT 03815354 T AT03815354 T AT 03815354T AT 03815354 T AT03815354 T AT 03815354T AT E479431 T1 ATE479431 T1 AT E479431T1
- Authority
- AT
- Austria
- Prior art keywords
- skin
- phototherapy
- salicylates
- antioxidants
- substances
- Prior art date
Links
- 208000012659 Joint disease Diseases 0.000 title abstract 2
- 150000004032 porphyrins Chemical class 0.000 title abstract 2
- 239000003963 antioxidant agent Substances 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000001126 phototherapy Methods 0.000 title 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 title 1
- 208000017520 skin disease Diseases 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 201000004624 Dermatitis Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 238000002428 photodynamic therapy Methods 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10301917A DE10301917B4 (de) | 2003-01-17 | 2003-01-17 | Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren |
| PCT/DE2003/004254 WO2004064827A1 (de) | 2003-01-17 | 2003-12-23 | Verwendung von substanzen der porphyrinsynthese für die anwendung in der phototherapie sowie zur behandlung von haut- und/oder gelenkerkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE479431T1 true ATE479431T1 (de) | 2010-09-15 |
Family
ID=32602752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03815354T ATE479431T1 (de) | 2003-01-17 | 2003-12-23 | Verwendung einer kombination von substanzen der porphyrinsynthese, salicylaten und antioxidantien bei der phototherapie von haut- und/oder gelenkerkrankungen |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20070099878A1 (enExample) |
| EP (1) | EP1583525B1 (enExample) |
| JP (1) | JP2006514072A (enExample) |
| AT (1) | ATE479431T1 (enExample) |
| AU (1) | AU2003300499A1 (enExample) |
| CY (1) | CY1110957T1 (enExample) |
| DE (2) | DE10301917B4 (enExample) |
| DK (1) | DK1583525T3 (enExample) |
| ES (1) | ES2351971T3 (enExample) |
| PT (1) | PT1583525E (enExample) |
| RU (1) | RU2336078C2 (enExample) |
| SI (1) | SI1583525T1 (enExample) |
| WO (1) | WO2004064827A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005019628A1 (de) * | 2005-04-26 | 2006-11-09 | Technische Universität Braunschweig | Formulierung zur dermalen Anwendung |
| DE102011117364A1 (de) * | 2011-10-29 | 2013-05-02 | Merck Patent Gmbh | Hautaufheller in der Phototherapie |
| DE202013003573U1 (de) | 2013-04-16 | 2013-06-04 | Gerhard Saalmann | Ganzkörper-Belichtungseinheit |
| RU2712806C1 (ru) * | 2019-05-20 | 2020-01-31 | Федеральное государственное бюджетное учреждение "Государственный научный центр лазерной медицины имени О.К. Скобелкина Федерального медико-биологического агентства" | Способ лечения больных перипротезной инфекцией после эндопротезирования сустава |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5145686A (en) * | 1982-02-03 | 1992-09-08 | Efamol Limited | Topical pharmaceutical compositions |
| IL68965A (en) * | 1983-06-13 | 1987-02-27 | Rafa Labor Ltd | Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders |
| US4647453A (en) * | 1984-10-18 | 1987-03-03 | Peritain, Ltd. | Treatment for tissue degenerative inflammatory disease |
| US5368841A (en) * | 1993-02-11 | 1994-11-29 | The General Hospital Corporation | Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides |
| DE4320871C2 (de) * | 1993-06-24 | 1995-05-04 | Beiersdorf Ag | Kosmetische und dermatologische Zubereitungen mit einem Gehalt an delta-Aminolävulinsäure |
| WO1996006602A1 (en) * | 1993-08-27 | 1996-03-07 | Noven Pharmaceuticals, Inc. | COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID AND PHARMACEUTICAL EQUIVALENTS THEREOF |
| DE4440112A1 (de) * | 1994-11-11 | 1996-05-15 | Jan H Dr Wilkens | Bestrahlungsanordnung zur Behandlung von Hauterkrankungen |
| US5530157A (en) * | 1995-02-16 | 1996-06-25 | Scios Nova Inc. | Anti-inflammatory benzoic acid derivatives |
| KR100444007B1 (ko) * | 1995-03-10 | 2004-12-03 | 포토큐레 에이에스에이 | 광화학치료또는진단에사용하기위한5-아미노레불린산의에스테르 |
| EP0959879B1 (en) * | 1996-10-10 | 2004-05-06 | The General Hospital Corporation | Photodynamic therapy for the treatment of osteoarthritis |
| RU2145247C1 (ru) * | 1998-04-10 | 2000-02-10 | Жаров Владимир Павлович | Фотоматричное терапевтическое устройство для лечения протяженных патологий |
| DE69940738D1 (de) * | 1998-07-09 | 2009-05-28 | Curelight Medical Ltd | Vorrichtung und verfahren zur wirkungsvollen hochenergetischen photodynamischen therapie von akne vulgaris und seborrhoe |
| DE19852245A1 (de) * | 1998-11-12 | 2000-05-18 | Asat Ag Applied Science & Tech | 5-Aminolävulinsäure-Nanoemulsion |
| DE10003620A1 (de) * | 2000-01-28 | 2001-08-02 | Asat Ag Applied Science & Tech | 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln |
| ES2243549T3 (es) * | 2000-09-08 | 2005-12-01 | Vivier Canada Inc. | Soluciones de acido ascorbico estabilizadas. |
| DE10063076A1 (de) | 2000-12-18 | 2002-06-27 | Medac Klinische Spezialpraep | Verwendung von 5-Aminolävulinsäure zur Restenose-Prophylaxe |
| CA2450370A1 (en) * | 2001-06-11 | 2002-12-19 | Jody Mesaros | Accelerators for increasing the rate of formation of free radicals and reactive oxygen species |
| US6723750B2 (en) * | 2002-03-15 | 2004-04-20 | Allergan, Inc. | Photodynamic therapy for pre-melanomas |
| US20040048842A1 (en) * | 2002-09-10 | 2004-03-11 | Mcmillan Kathleen | Method of treating skin disorders |
-
2003
- 2003-01-17 DE DE10301917A patent/DE10301917B4/de not_active Expired - Fee Related
- 2003-12-23 RU RU2005127035/15A patent/RU2336078C2/ru not_active IP Right Cessation
- 2003-12-23 US US10/542,355 patent/US20070099878A1/en not_active Abandoned
- 2003-12-23 ES ES03815354T patent/ES2351971T3/es not_active Expired - Lifetime
- 2003-12-23 DK DK03815354.0T patent/DK1583525T3/da active
- 2003-12-23 EP EP03815354A patent/EP1583525B1/de not_active Expired - Lifetime
- 2003-12-23 AT AT03815354T patent/ATE479431T1/de active
- 2003-12-23 PT PT03815354T patent/PT1583525E/pt unknown
- 2003-12-23 WO PCT/DE2003/004254 patent/WO2004064827A1/de not_active Ceased
- 2003-12-23 AU AU2003300499A patent/AU2003300499A1/en not_active Abandoned
- 2003-12-23 DE DE50313052T patent/DE50313052D1/de not_active Expired - Lifetime
- 2003-12-23 SI SI200331911T patent/SI1583525T1/sl unknown
- 2003-12-23 JP JP2004566721A patent/JP2006514072A/ja active Pending
-
2010
- 2010-12-01 CY CY20101101103T patent/CY1110957T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20070099878A1 (en) | 2007-05-03 |
| EP1583525A1 (de) | 2005-10-12 |
| ES2351971T3 (es) | 2011-02-14 |
| DE50313052D1 (de) | 2010-10-14 |
| DK1583525T3 (da) | 2011-01-03 |
| AU2003300499A1 (en) | 2004-08-13 |
| CY1110957T1 (el) | 2015-06-11 |
| RU2005127035A (ru) | 2006-01-27 |
| PT1583525E (pt) | 2010-12-07 |
| SI1583525T1 (sl) | 2011-01-31 |
| DE10301917B4 (de) | 2007-02-01 |
| WO2004064827A1 (de) | 2004-08-05 |
| JP2006514072A (ja) | 2006-04-27 |
| DE10301917A1 (de) | 2004-07-29 |
| RU2336078C2 (ru) | 2008-10-20 |
| EP1583525B1 (de) | 2010-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111177T1 (el) | Ενωση φαινοθειαζινιου για επουλωση τραυματων | |
| DK1660041T3 (da) | Ikke-polær fotosensibilisator til fotodynamisk terapi | |
| BRMU8400812Y1 (pt) | aperfeiçoamento introduzido em fonte de luz para tratamento da hiperbilirrubinemia por fototerapia. | |
| IL189019A0 (en) | Pdt (photodynamic therapy) treatment method for cellulites and cosmetic use | |
| ATE552000T1 (de) | Verwendung von isothiocyanat-verbindungen zur behandlung von prostata-erkrankungen und hautkrebs | |
| CY1119029T1 (el) | Θεραπευτικη αντιμετωπιση συμπαγων εγκεφαλικων νεοπλασιων με ενα παραγωγο ραπαμυκινης | |
| NO20021907D0 (no) | Metoder og blandinger som anvender kinazolinoner | |
| PT1296959E (pt) | Metodos e composicoes que utilizam quinazolinonas | |
| DE60037394D1 (de) | VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE | |
| ATE414514T1 (de) | Kombinationen, ein antidiarrhoikum und epothilon oder ein epothilonderivat enthaltend | |
| WO2002096366A3 (en) | Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy | |
| PA8568701A1 (es) | Compuestos que modulan la actividad de ppar | |
| PA8568601A1 (es) | Compuestos que modulan la actividad de ppar | |
| BR0315979A (pt) | Formulação oral de toxina botulìnica e uso da mesma para tratar úlceras pépticas e doença de refluxo gastroesofágico | |
| DK1754707T3 (da) | Multicykliske forbindelser og anvendelse deraf som inhibitorer af PARP-, VEGFR2- og MLK3-enzymer | |
| AU2003248747A1 (en) | Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy | |
| ATE409184T1 (de) | Dioxan-2-alkylkarbamaten derivaten, deren herstellung und deren therapeutischen verwendung | |
| CY2014007I1 (el) | Μεθοδοι για την αγωγη διαταραχων ή παθησεων που συσχετιζονται με υπερλιπιδαιμια και υπερχοληστερολαιμια ενω ελαχιστοποιουνται οι παρενεργειες | |
| DE602004029034D1 (de) | Replikin-peptide und anwendungen | |
| CY1115407T1 (el) | Θοριο-227 για χρηση στην ακτινοθεραπεια ασθενειων των μαλακων ιστων | |
| ATE442861T1 (de) | Gegen antikörper gerichtete photodynamische therapie | |
| CY1110957T1 (el) | Χρηση ουσιων της συνθεσης πορφυρινης σε συνδυασμο με σαλικυλικα και αντιοξειδωτικα για την εφαρμογη στην φωτοθεραπεια για την αγωγη δερματικων ασθενειων και/ή ασθενειων των αρθρωσεων | |
| WO2003028629A3 (en) | Chlorin photosensitizing agents for use in photodynamic therapy | |
| ATE453408T1 (de) | Farbstoff-sulfenate für die duale phototherapie | |
| WO2001062205A3 (en) | Treatment of vitiligo |